{"id":20429,"date":"2025-09-03T10:06:17","date_gmt":"2025-09-03T10:06:17","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=20429"},"modified":"2025-09-03T10:06:17","modified_gmt":"2025-09-03T10:06:17","slug":"medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/","title":{"rendered":"\u30e1\u30c7\u30a3\u30d1\u30eb\u3068JCR\u3001GM2\u6cbb\u7642\u85acJR-479\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u5951\u7d04\u3092\u7de0\u7d50"},"content":{"rendered":"<p>\u682a\u5f0f\u4f1a\u793e\u30e1\u30c7\u30a3\u30d1\u30eb\u30db\u30fc\u30eb\u30c7\u30a3\u30f3\u30b0\u30b9\u3068JCR\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30ba\u682a\u5f0f\u4f1a\u793e\u306f\u3001\u8d85\u5e0c\u5c11\u306a\u30e9\u30a4\u30bd\u30be\u30fc\u30e0\u8caf\u8535\u969c\u5bb3\u3067\u3042\u308bGM2\u30ac\u30f3\u30b0\u30ea\u30aa\u30b7\u30c9\u30fc\u30b7\u30b9\u6cbb\u7642\u85ac\u300cJR-479\u300d\u306b\u3064\u3044\u3066\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u3067\u306e\u72ec\u5360\u7684\u30e9\u30a4\u30bb\u30f3\u30b9\u5951\u7d04\u304a\u3088\u3073\u65e5\u672c\u306b\u304a\u3051\u308b\u5171\u540c\u958b\u767a\u30fb\u5546\u696d\u5316\u63d0\u643a\u3092\u7de0\u7d50\u3057\u305f\u3068\u767a\u8868\u3057\u307e\u3057\u305f\u3002.<\/p>\n<p>GM2\u30ac\u30f3\u30b0\u30ea\u30aa\u30b7\u30c9\u30fc\u30b7\u30b9\u306f\u3001\u30e9\u30a4\u30bd\u30be\u30fc\u30e0\u3067\u306eGM2\u30ac\u30f3\u30b0\u30ea\u30aa\u30b7\u30c9\u306e\u6b63\u5e38\u306a\u5206\u89e3\u3092\u59a8\u3052\u308b\u907a\u4f1d\u5b50\u5909\u7570\u306b\u3088\u3063\u3066\u5f15\u304d\u8d77\u3053\u3055\u308c\u308b\u3001\u307e\u308c\u306a\u907a\u4f1d\u6027\u75be\u60a3\u7fa4\u3067\u3042\u308a\u3001\u7279\u306b\u795e\u7d4c\u7d30\u80de\u306b\u304a\u3044\u3066\u84c4\u7a4d\u3092\u5f15\u304d\u8d77\u3053\u3057\u307e\u3059\u3002GM2\u30ac\u30f3\u30b0\u30ea\u30aa\u30b7\u30c9\u30fc\u30b7\u30b9\u306e\u6700\u3082\u4e00\u822c\u7684\u306a2\u3064\u306e\u30bf\u30a4\u30d7\u306f\u30c6\u30a4-\u30b5\u30c3\u30af\u30b9\u75c5\u3068\u30b5\u30f3\u30c9\u30db\u30d5\u75c5\u3067\u3001\u5909\u7570\u306e\u7a2e\u985e\u306b\u3088\u3063\u3066\u7570\u306a\u308a\u307e\u3059\u3002GM2\u30ac\u30f3\u30b0\u30ea\u30aa\u30b7\u30c9\u30fc\u30b7\u30b9\u306f\u3001\u4e16\u754c\u4e2d\u306730\u4e07\u4eba\u306b1\u4eba\u306e\u5272\u5408\u3067\u767a\u75c7\u3059\u308b\u3068\u63a8\u5b9a\u3055\u308c\u3001\u73fe\u5728\u627f\u8a8d\u3055\u308c\u305f\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u3001\u751f\u547d\u3092\u8105\u304b\u3059\u8d85\u5e0c\u5c11\u75be\u60a3\u3068\u8003\u3048\u3089\u308c\u3066\u3044\u307e\u3059\u3002.<\/p>\n<p>JR-479\u306f\u3001JCR\u72ec\u81ea\u306eJ-Brain Cargo\u00ae\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u3088\u308a\u958b\u767a\u3055\u308c\u305f\u65b0\u898f\u85ac\u5264\u5019\u88dc\u3067\u3001IZCARGO\u00ae\u70b9\u6ef4\u9759\u6ce8\u752810mg\u306b\u3088\u308a\u81e8\u5e8a\u7684\u306b\u691c\u8a3c\u3055\u308c\u3001\u30e9\u30a4\u30bd\u30be\u30fc\u30e0\u8caf\u8535\u969c\u5bb3\u306e\u6cbb\u7642\u85ac\u3068\u3057\u30662021\u5e74\u306b\u65e5\u672c\u3067\u627f\u8a8d\u3092\u53d6\u5f97\u3057\u307e\u3057\u305f\u3002\u524d\u81e8\u5e8a\u8a66\u9a131 \u306b\u304a\u3044\u3066\u3001JR-479 \u306f\u4e2d\u67a2\u795e\u7d4c\u7cfb\u3092\u542b\u3080\u5168\u8eab\u306b\u9001\u9054\u3055\u308c\u3001\u75be\u60a3\u95a2\u9023\u57fa\u8cea\u3092\u6e1b\u5c11\u3055\u305b\u3001\u52d5\u7269\u30e2\u30c7\u30eb\u306b\u304a\u3044\u3066\u751f\u5b58\u671f\u9593\u3092\u5ef6\u9577\u3057\u307e\u3057\u305f\u3002.<\/p>\n<h4>\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a class=\"p-url\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/eisais-tazemetostat-approved-as-orphan-drug-in-japan\/\" rel=\"bookmark\">\u30a8\u30fc\u30b6\u30a4\u306e\u30bf\u30bc\u30e1\u30c8\u30b9\u30bf\u30c3\u30c8\u304c\u65e5\u672c\u3067\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u306b\u6307\u5b9a<\/a><\/h4>\n<p>\u4eca\u56de\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u30e9\u30a4\u30bb\u30f3\u30b9\u5951\u7d04\u306b\u3088\u308a\u3001\u30e1\u30c7\u30a3\u30d1\u30eb\u306fJR-479\u306e\u958b\u767a\u3001\u88fd\u9020\u3001\u5546\u696d\u5316\u306b\u95a2\u3059\u308b\u5168\u4e16\u754c\uff08\u65e5\u672c\u3092\u9664\u304f\uff09\u3067\u306e\u72ec\u5360\u7684\u6a29\u5229\u3092\u6709\u3057\u3001\u30b5\u30d6\u30e9\u30a4\u30bb\u30f3\u30b9\u6a29\u3082\u6709\u3057\u307e\u3059\u3002\u65e5\u672c\u3067\u306f\u3001\u30e1\u30c7\u30a3\u30d1\u30eb\u304c\u5171\u540c\u958b\u767a\u3092\u901a\u3058\u3066\u81e8\u5e8a\u8a66\u9a13\u306e\u30ed\u30b8\u30b9\u30c6\u30a3\u30af\u30b9\u3001\u75be\u60a3\u5553\u767a\u306e\u652f\u63f4\u3001\u696d\u52d9\u306e\u652f\u63f4\u3092\u884c\u3044\u3001JCR\u304c\u5546\u696d\u5316\u3092\u4e3b\u5c0e\u3057\u3001\u56fd\u5185\u3067\u306e\u53ce\u76ca\u3092\u8a08\u4e0a\u3057\u307e\u3059\u3002\u307e\u305f\u3001JCR\u306f\u5951\u7d04\u4e00\u6642\u91d1\u304a\u3088\u3073\u6d77\u5916\u58f2\u4e0a\u9ad8\u306b\u5fdc\u3058\u305f\u30ed\u30a4\u30e4\u30eb\u30c6\u30a3\u3092\u53d7\u3051\u53d6\u308a\u307e\u3059\u3002.<\/p>\n<p>\u672c\u5951\u7d04\u306b\u3088\u308a\u3001JR-479\u306f\u3001\u4ee5\u4e0b\u306e\u6226\u7565\u7684\u63d0\u643a\u306b\u52a0\u308f\u308a\u307e\u3059\u3002 <a href=\"https:\/\/www.medipal.co.jp\/\">\u30e1\u30c7\u30a3\u30d1\u30eb<\/a> \u305d\u3057\u3066 <a href=\"https:\/\/www.jcrpharm.co.jp\/\">JCR<\/a>, JR-479\u306f\u30012022\u5e7410\u6708\u306b\u767a\u58f2\u3055\u308c\u305f\u3001\u8d85\u5e0c\u5c11\u75be\u60a3\u306e\u6cbb\u7642\u85ac\u958b\u767a\u306b\u95a2\u3059\u308b\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3067\u3059\u3002JR-479\u306f\u3001\u30d5\u30b3\u30b7\u30c9\u30fc\u30b7\u30b92\u6cbb\u7642\u85acJR-471\u3001\u30e0\u30b3\u591a\u7cd6\u75c7IIIB\u578b3\u6cbb\u7642\u85acJR-446\u306b\u7d9a\u304f3\u756a\u76ee\u306e\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3068\u306a\u308a\u307e\u3059\u3002.<\/p>\n<p>\u4e21\u793e\u306f\u3001\u672c\u5408\u610f\u306b\u3088\u308b\u696d\u7e3e\u3078\u306e\u5f71\u97ff\u3092\u65e2\u306b2026\u5e743\u6708\u671f\u306e\u9023\u7d50\u696d\u7e3e\u4e88\u60f3\u306b\u7e54\u308a\u8fbc\u3093\u3067\u304a\u308a\u307e\u3059\u3002.<\/p>\n<p><strong>\u30bd\u30fc\u30b9 <a href=\"https:\/\/www.businesswire.com\/news\/home\/20250902432425\/en\/MEDIPAL-HOLDINGS-and-JCR-Pharmaceuticals-Sign-Global-Licensing-and-Japan-Co-Development-Agreement-for-JR-479-a-Novel-Therapy-for-GM2-Gangliosidosis\">\u30d3\u30b8\u30cd\u30b9\u30ef\u30a4\u30e4\u30fc<\/a><\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the two companies have signed an exclusive global licensing deal and a co-development and commercialization partnership in Japan for JR-479, an investigational therapy for GM2 gangliosidosis, an ultra-rare lysosomal storage disorder. GM2 gangliosidoses are a group of rare, inherited disorders caused by genetic mutations that prevent the normal breakdown of GM2 gangliosides in lysosomes, leading to their buildup, especially in neurons. Tay-Sachs disease and Sandhoff disease are the two most common types of GM2 gangliosidosis depending on the specific mutation. GM2 gangliosidosis affects an estimated one in 300,000 people worldwide and is considered an ultra-rare, life-threatening disorder for which no [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":20430,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[208,89,211,237,182,206],"tags":[7560,7562,7561,7563,424],"ppma_author":[205],"class_list":{"0":"post-20429","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-apac","8":"category-health-tech","9":"category-japan","10":"category-news","11":"category-pharma","12":"category-regional","13":"tag-gm2-gangliosidosis","14":"tag-jcr-pharmaceuticals","15":"tag-jr-479","16":"tag-medipal-holdings","17":"tag-pharma"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MEDIPAL, JCR Partner Globally on GM2 Therapy JR-479<\/title>\n<meta name=\"description\" content=\"MEDIPAL and JCR sign global licensing and Japan co-development deal for JR-479, an investigational therapy for ultra-rare GM2 gangliosidosis.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MEDIPAL, JCR Partner Globally on GM2 Therapy JR-479\" \/>\n<meta property=\"og:description\" content=\"MEDIPAL and JCR sign global licensing and Japan co-development deal for JR-479, an investigational therapy for ultra-rare GM2 gangliosidosis.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-03T10:06:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/MEDIPAL-HOLDINGS-and-JCR-Pharmaceuticals-Sign-Global-Licensing-and-Japan-Co-Development-Agreement-for-JR-479_-a-Novel-Therapy-for-GM2-Gangliosidosis.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NewsDesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"NewsDesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30e1\u30c7\u30a3\u30d1\u30eb\u3001JCR\u3068GM2\u7642\u6cd5JR-479\u3067\u30b0\u30ed\u30fc\u30d0\u30eb\u63d0\u643a","description":"\u30e1\u30c7\u30a3\u30d1\u30eb\u3068JCR\u3001\u8d85\u5e0c\u5c11\u75be\u60a3GM2\u30ac\u30f3\u30b0\u30ea\u30aa\u30b7\u30c9\u30fc\u30b7\u30b9\u6cbb\u7642\u85acJR-479\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u30e9\u30a4\u30bb\u30f3\u30b9\u5951\u7d04\u304a\u3088\u3073\u65e5\u672c\u306b\u304a\u3051\u308b\u5171\u540c\u958b\u767a\u5951\u7d04\u3092\u7de0\u7d50.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/","og_locale":"ja_JP","og_type":"article","og_title":"MEDIPAL, JCR Partner Globally on GM2 Therapy JR-479","og_description":"MEDIPAL and JCR sign global licensing and Japan co-development deal for JR-479, an investigational therapy for ultra-rare GM2 gangliosidosis.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/","og_site_name":"itbusinesstoday","article_published_time":"2025-09-03T10:06:17+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/MEDIPAL-HOLDINGS-and-JCR-Pharmaceuticals-Sign-Global-Licensing-and-Japan-Co-Development-Agreement-for-JR-479_-a-Novel-Therapy-for-GM2-Gangliosidosis.webp","type":"image\/webp"}],"author":"NewsDesk","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"NewsDesk","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/"},"author":{"name":"NewsDesk","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812"},"headline":"MEDIPAL and JCR Ink Global Deal for GM2 Drug JR-479","datePublished":"2025-09-03T10:06:17+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/"},"wordCount":319,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/MEDIPAL-HOLDINGS-and-JCR-Pharmaceuticals-Sign-Global-Licensing-and-Japan-Co-Development-Agreement-for-JR-479_-a-Novel-Therapy-for-GM2-Gangliosidosis.webp","keywords":["GM2 Gangliosidosis","JCR Pharmaceuticals","JR-479","MEDIPAL HOLDINGS","Pharma"],"articleSection":["APAC","Health Tech","Japan","News","Pharma","Regional"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/","name":"\u30e1\u30c7\u30a3\u30d1\u30eb\u3001JCR\u3068GM2\u7642\u6cd5JR-479\u3067\u30b0\u30ed\u30fc\u30d0\u30eb\u63d0\u643a","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/MEDIPAL-HOLDINGS-and-JCR-Pharmaceuticals-Sign-Global-Licensing-and-Japan-Co-Development-Agreement-for-JR-479_-a-Novel-Therapy-for-GM2-Gangliosidosis.webp","datePublished":"2025-09-03T10:06:17+00:00","description":"\u30e1\u30c7\u30a3\u30d1\u30eb\u3068JCR\u3001\u8d85\u5e0c\u5c11\u75be\u60a3GM2\u30ac\u30f3\u30b0\u30ea\u30aa\u30b7\u30c9\u30fc\u30b7\u30b9\u6cbb\u7642\u85acJR-479\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u30e9\u30a4\u30bb\u30f3\u30b9\u5951\u7d04\u304a\u3088\u3073\u65e5\u672c\u306b\u304a\u3051\u308b\u5171\u540c\u958b\u767a\u5951\u7d04\u3092\u7de0\u7d50.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/MEDIPAL-HOLDINGS-and-JCR-Pharmaceuticals-Sign-Global-Licensing-and-Japan-Co-Development-Agreement-for-JR-479_-a-Novel-Therapy-for-GM2-Gangliosidosis.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/09\/MEDIPAL-HOLDINGS-and-JCR-Pharmaceuticals-Sign-Global-Licensing-and-Japan-Co-Development-Agreement-for-JR-479_-a-Novel-Therapy-for-GM2-Gangliosidosis.webp","width":1200,"height":800,"caption":"MEDIPAL HOLDINGS"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/medipal-and-jcr-ink-global-deal-for-gm2-drug-jr-479\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"MEDIPAL and JCR Ink Global Deal for GM2 Drug JR-479"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/d58d81f55e8acd257ab63d49fb4ea812","name":"\u30cb\u30e5\u30fc\u30b9\u30c7\u30b9\u30af","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png74f313ad3d6fa27a1eee85c30be63d03","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","caption":"NewsDesk"},"sameAs":["https:\/\/itbusinesstoday.com"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/newsdesk\/"}]}},"authors":[{"term_id":205,"user_id":4,"is_guest":0,"slug":"newsdesk","display_name":"NewsDesk","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/it.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/20429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=20429"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/20429\/revisions"}],"predecessor-version":[{"id":20431,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/20429\/revisions\/20431"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/20430"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=20429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=20429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=20429"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=20429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}